1. You Are At:
  2. Home
  3. Search All


'ranbaxy' - 35 Search Result(s)

  • Former Ranbaxy promoters Malvinder Singh and Shivinder

    Ranbaxy row: HC bars Singh bothers from stake sale without court nod

    March 07, 2017 12:56 IST

    The court’s directions came on an interim application by Japanese conglomerate Daiichi Sankyo, which had bought a majority stake in Ranbaxy in 2008

  • ranbaxy

    Big blow to Ranbaxy brothers, court asks them to pay Rs 2,562 crore fine to Daiichi

    May 06, 2016 11:52 IST

    New Delhi: Former owners of Ranbaxy Laboratories Malvinder Singh and Shivinder Mohan Singh, have been asked by a Singapore court to pay damages worth $400 million (over Rs 2,500 crore) to Japan's Daiichi Sankyo Co.

  • shivinder mohan singh of fortis renounces business to join

    Shivinder Mohan Singh of Fortis renounces business to join spiritual sect

    September 25, 2015 19:01 IST

    New Delhi: The co-founder of Fortis Healthcare, Shivinder Mohan Singh, has sprung a surprise by renouncing the corporate world and joining a spiritual organisation. The 40-year-old responded to a higher calling and will soon be

  • us lawsuit puts generic drug imports from india under

    US lawsuit puts generic drug imports from India under scanner

    May 16, 2015 11:05 IST

    Washington: A US class action lawsuit accusing India's Ranbaxy of large-scale deception on its generic drug applications puts a question mark on drug imports from India, the largest supplier of generic drugs to the US.The

  • salmanverdict who will suffer the most if he gets convicted

    #Salmanverdict: Who will suffer the most if he gets convicted?

    Bollywood | May 05, 2015 12:03 IST

    May 6th, the judgment day of actor Salman Khan's hit-and-run case is not only critical for him but for several others who are associated with the megastar. As per a media reports, around 2000 crore

  • sun pharma ranbaxy merger finalized a year after

    Sun Pharma, Ranbaxy merger finalized, a year after announcement

    March 24, 2015 23:55 IST

    New Delhi: Sun Pharmaceutical Industries today said that its merger with Ranbaxy has been 'consummated' following receipt of requisite approvals, almost a year it announced the $4 billion deal.In a filing to the BSE, the

  • sun gets us trade regulator nod for ranbaxy merger

    Sun gets US trade regulator nod for Ranbaxy merger

    February 01, 2015 11:52 IST

    New Delhi: Drug major Sun Pharma is now a step closer to becoming the world's fifth-largest generic drug company, as the US Federal Trade Commission (USFTC) has given a conditional nod for the proposed $4-billion

  • us regulator imposes conditions on sun s ranbaxy acquisition

    US regulator imposes conditions on Sun's Ranbaxy acquisition

    January 31, 2015 7:13 IST

    Washington: An American federal trade regulator today imposed conditions on Sun Pharmaceuticals' acquisition of Ranbaxy on the grounds that the USD 4 billion proposed deal would likely be anti-competitive.The Federal Trade Commission (FTC) said pharmaceutical

  • us fda forfeits ranbaxy s exclusivity for stomach drugs

    US FDA forfeits Ranbaxy's exclusivity for stomach drugs

    January 27, 2015 16:12 IST

    New Delhi: Drug major Ranbaxy said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity for stomach and esophagus problems treatment tablets."We have now received a

  • ranbaxy posts rs 477.75 cr net profit in q2

    Ranbaxy posts Rs 477.75-cr net profit in Q2

    October 28, 2014 14:52 IST

    New Delhi: Drug maker Ranbaxy Laboratories has posted a net profit of Rs 477.75 crore for the quarter-ended September 30 due to strong topline, lower expenses and operational performance despite higher finance and tax cost,

  • cci says sun ranbaxy deal may hit competition seeks comments

    CCI says Sun-Ranbaxy deal may hit competition; seeks comments

    September 05, 2014 0:06 IST

    New Delhi: Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today said it has prima facie found that the USD 4-billion merger of Ranbaxy Labs into rival Sun

  • ranbaxy gets fda nod to sell generic diovan tablets in us

    Ranbaxy gets FDA nod to sell generic Diovan tablets in US

    June 27, 2014 18:22 IST

    New Delhi: Drug major Ranbaxy Laboratories has received the U.S. health regulator's approval to market a generic version of Novartis' Diovan tablets, used for treating high blood pressure and heart failure, in the U.S. with

  • andhra hc lifts stay on merger between ranbaxy and sun

    Andhra HC lifts stay on merger between Ranbaxy and Sun Pharma

    May 24, 2014 16:05 IST

    Hyderabad: The Andhra Pradesh High Court today vacated a status quo order it had issued earlier on Sun Pharma-Ranbaxy merger process, paving the way for the pharma giants becoming a single entity.While vacating the status

  • sc asks andhra hc to decide on ranbaxy sun pharma merger

    SC asks Andhra HC to decide on Ranbaxy-Sun Pharma merger

    May 21, 2014 16:19 IST

    New Delhi: The Supreme Court today asked the Andhra Pradesh High Court, which had passed an interim order staying the $4 billion merger of Ranbaxy with Sun Pharma, to decide the issue within two days.Hearing

  • ranbaxy laboratories posts surprise march quarter loss on

    Ranbaxy Laboratories posts surprise March-quarter loss on write-offs

    May 09, 2014 16:59 IST

    New Delhi: Drug major Ranbaxy Laboratories Ltd today posted consolidated net loss of Rs 73.6 crore for the fourth quarter ended March 31, 2014 Ranbaxy Laboratories had posted net profit of Rs 125.75 crore during the

  • ranbaxy s journey as a company to end after merger with sun

    Ranbaxy's journey as a company to end after merger with Sun

    April 20, 2014 19:46 IST

    New Delhi: Ranbaxy  Laboratories will cease to exist as a company after completion of the $ 4 billion merger with Sun Pharmaceuticals, although its brands will be kept alive in over 100 markets. “The Ranbaxy entity

  • ranbaxy recalls generic lipitor in u.s.

    Ranbaxy recalls generic Lipitor in U.S.

    March 09, 2014 19:48 IST

    New Delhi: Ranbaxy Laboratories, facing a host of regulatory issues, has recalled two batches of the company's generic version of Pfizer's cholesterol-lowering medicine Lipitor after a dose mix-up was detected. The company recalled the tablets

  • flies in ranbaxy s toansa plant s sample storage room us

    Flies in Ranbaxy's Toansa plant's sample storage room: US drug inspectors

    January 27, 2014 10:11 IST

    New Delhi: Presence of flies in sample storage room, un-calibrated instruments in laboratory and non-adherence to sample analysis procedure were among the alleged lapses found in Ranbaxy's Toansa plant that led to US health regulator

  • singh brothers count on disclosure to counter daiichi claims

    Singh brothers count on disclosure to counter Daiichi claims

    November 18, 2013 11:25 IST

    New Delhi: Facing arbitration claims by Daiichi Sankyo, Ranbaxy's former Indian promoters - Malvinder Mohan Singh, his brother Shivinder Mohan Singh and family - are counting on certain clauses in the share purchase agreement (SPA)

  • nifty recovers early losses remains above 5 900 mark

    Nifty recovers early losses; remains above 5,900 mark

    October 07, 2013 20:49 IST

    Mumbai: The benchmark CNX Nifty of the National Stock Exchange (NSE) erased early losses and closed almost flat for the second straight trading session today on tail-end buying that helped it to hold on to

Read More

Live Scorecard